Latest filing published 04 Jun 2025 for Pulmonx Corp.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Dana G. Mead Jr. is a declared insider at 5 companies; the most frequent names are Pulmonx Corp, Intersect ENT, Inc. and Inari Medical, Inc. We count 32 filings; the first trade dates from 3 March 2016 and the latest from 2 June 2025.
On the market, this insider has only ever bought: 4 purchases, €874k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 18 share grants.
In size, the median ticket on the buying side is €182k. On 3 out of 4 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
On 4 June 2025 came the latest disclosure, a share grant in Pulmonx Corp. The last purchase on record was published on 5 October 2020, which is 2,209 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations